eMedicine Specialties > Ophthalmology > Lacrimal System

Dacryoadenitis

Author: Gagan J Singh, MD, Chief of Ophthalmology, GMS Medical Eye Center, LLC
Coauthor(s): Richard Ahuja, MD, Clinical Instructor, Department of Ophthalmology, University of Maryland Medical School
Contributor Information and Disclosures

Updated: Mar 19, 2009

Introduction

Background

The lacrimal gland is located in the supratemporal orbit. Two lobes exist, the orbital and the palpebral. The palpebral lobe is visualized easily by upper lid eversion. This eccrine secretory gland is responsible for the formation of the aqueous layer of the tear film.

By definition, dacryoadenitis is an inflammatory enlargement of the lacrimal gland. Dacryoadenitis may be separated into acute and chronic syndromes with infectious or systemic etiology.

Pathophysiology

The pathophysiology is not understood completely. Yet, infectious dacryoadenitis is thought to be caused by ascension of an inciting agent from the conjunctiva through the lacrimal ductules into the lacrimal gland.

Frequency

United States

Dacryoadenitis is uncommon; therefore, data about its prevalence are sparse. One in 10,000 ophthalmic patients has dacryoadenitis according to one report. Inflammatory enlargement of the lacrimal gland is much more common than lacrimal gland tumors.

Mortality/Morbidity

No data are available. Acute dacryoadenitis tends to be a self-limiting condition. Patients with chronic dacryoadenitis need management of their systemic condition.

Race

No racial predilection is noted.

Sex

No sexual predilection is noted.

Age

No age predilection is noted.

Clinical

History

  • Acute dacryoadenitis
    • Unilateral, severe pain, redness, and pressure in the supratemporal region of the orbit
    • Rapid onset (hours to days)
  • Chronic dacryoadenitis
    • Can be bilateral, painless enlargement of the lacrimal gland present for more than a month
    • More common than acute dacryoadenitis

Physical

  • Acute dacryoadenitis
    • The palpebral lobe of the lacrimal gland is often involved and is easily seen by everting the upper lid. It is noted to be prolapsed and enlarged. The palpebral lobe tends to be firm and tender upon palpation through the lid.
    • Other associated ophthalmic physical signs of acute dacryoadenitis include the following:
      • Chemosis (conjunctival swelling)
      • Conjunctival injection
      • Mucopurulent discharge
      • Erythema of eyelids
      • Lymphadenopathy (submandibular)
      • Swelling of the lateral third of the upper lid (S-shaped lid)
      • Proptosis
      • Ocular motility restriction
      • Globe displacement inferiorly and medially
      • Increased severity of signs and symptoms with orbital lobe involvement
      • Acanthamoeba keratitis associated (rarely)
    • Systemic physical signs of acute dacryoadenitis include the following:  
      • Parotid gland enlargement
      • Fever
      • Upper respiratory infection
      • Malaise
  • Chronic dacryoadenitis
    • Less severe presentation than acute dacryoadenitis
    • No pain (usually)
    • Enlarged gland but mobile
    • Minimal ocular signs
    • Mild ptosis secondary to enlargement of the gland (possible)
    • Mild-to-severe dry eyes

Causes

  • Infectious
    • Viral (most common)
      • Mumps (most common, especially in childhood)
      • Epstein-Barr virus
      • Herpes zoster
      • Mononucleosis
      • Cytomegalovirus
      • Echoviruses
      • Coxsackievirus A
    • Bacterial
      • Staphylococcus aureus1 and Streptococcus
      • Neisseria gonorrhoeae
      • Treponema pallidum
      • Chlamydia trachomatis
      • Mycobacterium leprae
      • Mycobacterium tuberculosis
      • Borrelia burgdorferi2
    • Fungal (rare)
      • Histoplasmosis
      • Blastomycosis
      • Parasite (rare)
      • Schistosoma haematobium
      • Protozoa (rare)
      • Acanthamoeba keratitis associated
  • Inflammatory

More on Dacryoadenitis

Overview: Dacryoadenitis
Differential Diagnoses & Workup: Dacryoadenitis
Treatment & Medication: Dacryoadenitis
Follow-up: Dacryoadenitis
References
[ CLOSE WINDOW ]

References

  1. Kubal A, Garibaldi DC. Dacryoadenitis caused by methicillin-resistant Staphylococcus aureus. Ophthal Plast Reconstr Surg. Jan-Feb 2008;24(1):50-1. [Medline].

  2. Nieto JC, Kim N, Lucarelli MJ. Dacryoadenitis and orbital myositis associated with lyme disease. Arch Ophthalmol. Aug 2008;126(8):1165-6. [Medline].

  3. Kamao T, Miyazaki T, Soga Y, et al. Genetic dissociation of dacryoadenitis and sialadenitis in a Sjogren's syndrome mouse model with common and different susceptibility gene loci. Invest Ophthalmol Vis Sci. Feb 14 2009;[Medline].

  4. Boruchoff SA, Boruchoff SE. Infections of the lacrimal system. Infect Dis Clin North Am. Dec 1992;6(4):925-32. [Medline].

  5. Brindley GO. Dacryoadenitis. In: Oculoplastic and Orbital Emergencies. Appleton & Lange: 1990:45-50.

  6. Fitzsimmons TD, Wilson SE, Kennedy RH. Infectious dacryoadenitis. In: Ocular Infection and Immunity. St Louis, Mo: Mosby; 1996:1341-45.

  7. Jakobiec FA, Yeo JH, Trokel SL, et al. Combined clinical and computed tomographic diagnosis of primary lacrimal fossa lesions. Am J Ophthalmol. Dec 1982;94(6):785-807. [Medline].

  8. Massaro BM, Tabbara KF. Infections of lacrimal apparatus. In: Infections of the Eye. Boston: Little Brown; 1996:551-8.

  9. Podos SM, Yanoff M. Acute dacryoadenitis. In: Textbook of Ophthalmology - External Disease. Europe: Mosby-Year Book; 1994:1414-6.

  10. Rhem MN, Wilhelmus KR, Jones DB. Epstein-Barr virus dacryoadenitis. Am J Ophthalmol. Mar 2000;129(3):372-5. [Medline].

  11. Tomita M, Shimmura S, Tsubota K, Shimazaki J. Dacryoadenitis associated with Acanthamoeba keratitis. Arch Ophthalmol. Sep 2006;124(9):1239-42. [Medline].

[ CLOSE WINDOW ]

Further Reading

[ CLOSE WINDOW ]

Keywords

dacryoadenitis, acute dacryoadenitis, chronic dacryoadenitis, lacrimal gland, lacrimal gland inflammation, inflammation of lacrimal gland, inflammatory enlargement of lacrimal gland, lacrimal gland tumors

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

Gagan J Singh, MD, Chief of Ophthalmology, GMS Medical Eye Center, LLC
Gagan J Singh, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Ophthalmology, and American Society of Cataract and Refractive Surgery
Disclosure: Nothing to disclose.

Coauthor(s)

Richard Ahuja, MD, Clinical Instructor, Department of Ophthalmology, University of Maryland Medical School
Richard Ahuja, MD is a member of the following medical societies: American Academy of Ophthalmology and American Medical Association
Disclosure: Nothing to disclose.

Medical Editor

Ron W Pelton, MD, PhD, Private Practice, Colorado Springs, Colorado
Ron W Pelton, MD, PhD is a member of the following medical societies: American Academy of Ophthalmology, American Medical Association, American Society of Ophthalmic Plastic and Reconstructive Surgery, Colorado Medical Society, Utah Medical Association, and Wilderness Medical Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Simon K Law, MD, PharmD, Assistant Professor of Ophthalmology, Jules Stein Eye Institute; Chief of Section of Ophthalmology Surgical Services, Department of Veterans Affairs Healthcare Center, West Los Angeles
Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, and Association for Research in Vision and Ophthalmology
Disclosure: Nothing to disclose.

Managing Editor

Mark T Duffy, MD, PhD, Consulting Staff, Division of Oculoplastic, Orbito-facial, Lacrimal and Reconstructive Surgery, Green Bay Eye Clinic, BayCare Clinic; Medical Director, Advanced Cosmetic Solutions, A BayCare Clinic
Mark T Duffy, MD, PhD is a member of the following medical societies: American Academy of Ophthalmology, American Medical Association, American Society of Ophthalmic Plastic and Reconstructive Surgery, Sigma Xi, and Society for Neuroscience
Disclosure: Allergan - Botox Cosmetic Consulting fee Consulting; Quest medical - lacrimal balloons Honoraria Speaking and teaching; Ortho-Neutrogenia Consulting fee Consulting

CME Editor

Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri
Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences
Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology
Disclosure: Nothing to disclose.

RELATED EMEDICINE ARTICLES
 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.